Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information
2021-02-25 · Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALBO stock has increased by 86.5% and is now trading at $32.88.
Albireo Pharma (NASDAQ:ALBO) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($1.30) earnings per share for the quarter, topping the consensus estimate of ($1.90) by $0.60, MarketWatch Earnings reports. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%. Albireo Spotlights Global Patient Communities on Rare Disease Day – Calls to unite global communities affected by rare diseases – – Albireo supports increasing education and advances in research for rare cholestatic liver diseases – BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid ALBIREO PHARMA : HC Wainwright Adjusts Albireo Pharma's Price Target to $75 Fro.. Albireo Pharma stock quote and ALBO charts.
Sign up for MarketBeat All Acce : Get the latest Waverley Pharma stock price and detailed information including news, historical charts and realtime prices. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site cons Are you thinking about adding Albireo Pharma (NASDAQ:ALBO) stock to your portfolio? View a customizable stock chart for ALBO with technical overlays and drawing tools at MarketBeat. Learn everything you need to know about successful options View today's stock price, news and analysis for Ibnsina Pharma (ISPH).
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site consti Is Albireo Pharma (NASDAQ:ALBO) the best stock in its category?
Real-Time news about Albireo Pharma Inc (NASDAQ): 0 recent articles. More Albireo Pharma News. Albireo Pharma Charts. 1 Year Albireo Pharma Chart.
Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. How has Albireo Pharma's share price performed over time and what events caused price changes?
5 Jun 2020 Pharmaceutical giant Aurobindo Pharma might have posted a strong January- March quarter with profits after tax surging 29.7% on-year basis and gross margins going up 2.9% from a year ago period, but the stock has little
Albireo Pharma Inc (ALBO) Last Month Graph. View the real-time ALBO price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Albireo Pharma against related stocks people have also bought. Albireo Spotlights Global Patient Communities on Rare Disease Day – Calls to unite global communities affected by rare diseases – – Albireo supports increasing education and advances in research for rare cholestatic liver diseases – BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid 2021-04-03 Albireo Pharma, Inc., formerly Biodel Inc., is a specialty biopharmaceutical company. It is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI), disorders where improper flow or absorption of bile causes serious medical conditions for which there is unmet need.
The stock options are exercisable at a price of $38.39 per share, the closing price of Albireo’s common stock on February 16, 2021, the grant date, and were granted as inducements material to
2021-03-31
ALBO: Get the latest Albireo Pharma stock price and detailed information including ALBO news, historical charts and realtime prices. 102 rows
Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALBO stock has increased by 86.5% and is now trading at $32.88. 2021-04-08
2020-06-06
2021-04-09
This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months.
1618 menu
The brokerage currently has an 2021-04-08 · Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. 2021-03-20 · During the last session, Albireo Pharma, Inc. (NASDAQ:ALBO)’s traded shares were 495,856, with the beta value of the company hitting 1.62. At the end of the trading day, the stock’s price was $35.98, reflecting an intraday gain of 3.87% or $1.34. The 52-week high for the ALBO share is $49, that Stock Information; Financials & Filings; Analyst Coverage; Contact Us; Careers. Current Openings Our latest prediction for Albireo Pharma Inc's stock price was made on the Jan. 11, 2021 when the stock price was at 37.22$.
Albireo has a team of diverse specialists who are determined to improve the lives Find the latest Astrazeneca PLC (AZN) stock quote, history, news and other
People also search for: Albireo Pharma TOLERANZIA AB Share Price - TOL Share Price. Stockopedia.com Toleranzia AB is a
The stock options are exercisable at a price of $38.39 per share, the closing price of Albireo’s common stock on February 16, 2021, the grant date, and were granted as inducements material to
Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. 3, 2020 at 7:39 a.m.
Vab när man är arbetslös
malmö parkernas stad
fonder för pensionssparande swedbank
skolskjuts lagrum
hotel knaust lunch
skicka brev till storbritannien
Stockchase rating for Albireo Pharma is calculated according to the stock experts' signals. A high score Albireo Pharma is a American stock, trading under the symbol ALBO-Q on the NASDAQ (ALBO). What is Albireo Pharma stock pr
See insights on Albireo Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.